Voice changes in women treated for endometriosis and related conditions: The need for comprehensive vocal assessment

M A Pattie; Moya A. Pattie; Pattie MA; Murdoch BE; Bruce E. Murdoch; B E Murdoch; Theodoros D; Deborah Theodoros; D Theodoros; K Forbes; Kevin L Forbes; Forbes K

doi:10.1016/s0892-1997(98)80027-1

Voice changes in women treated for endometriosis and related conditions: The need for comprehensive vocal assessment

M A Pattie, Moya A. Pattie, Pattie MA, Murdoch BE, Bruce E. Murdoch, B E Murdoch, Theodoros D, Deborah Theodoros, D Theodoros, K Forbes, Kevin L Forbes, Forbes K

Journal of voice : official journal of the Voice Foundation · 1998 · vol. 12(3) , pp. 366–371 · doi:10.1016/s0892-1997(98)80027-1 · PMID:9763187 · W1998576835

article OA: closed CC0

View on OpenAlex View on PubMed View at publisher

⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This paper highlights the need for comprehensive vocal assessments in women undergoing treatment for endometriosis due to potential voice changes.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Hormonal treatments which have an androgenic effect have the potential to cause vocal changes. The changes in vocal fold structure and voice quality are considered to be irreversible. To date, studies have documented subjective vocal changes or documented single cases without detailed, baseline voice assessments. The impact on laryngeal function of women taking these androgenic treatments requires further detailed, objective assessment. The need for increased awareness of the actions of androgenic hormones on womens' voices, and the benefits of a thorough voice assessment are discussed.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Danazol Danazol Endometriosis Estrogen Antagonists Estrogen Antagonists Voice Voice Disorders Voice Quality Danazol Endometriosis Estrogen Antagonists Female Humans Voice Voice Disorders

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (45)

A comparative study of danazol, a regimen of decreasing doses of danazol, and norethindrone in the treatment of objectively proven unexplained menorrhagia via openalex
A Comparative Treatment Trial of Endometriosis Using the Gonadotrophin‐releasing Hormone Agonist, Nafarelin, and the Synthetic Steroid, Danazol via openalex
Action of danazol on plasma lipids and lipoprotein metabolism. via openalex
A randomized double-blind prospective trial of two doses of gestrinone in the treatment of endometriosis via openalex
Effect Of Danazol On Vocal Pitch - A Case-study via openalex
Endometriosis—Associated Infertility via openalex
ETIOLOGY, PREVENTION, AND INHIBITION OF ENDOMETRIOSIS via openalex
Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis. via openalex
Goserelin (Zoladex) and the skeleton via openalex
Goserelin (Zoladex ) depot in the treatment of endometriosis via openalex
Hormonal therapies for endometriosis: implications for bone metabolism. via openalex
Incidence of endometriosis in diagnostic laparoscopy. via openalex
LAPAROSCOPIC DIAGNOSIS AND PSEUDOMENOPAUSE TREATMENT OF ENDOMETRIOSIS WITH DANAZOL via openalex
Laparoscopy in the diagnosis and management of endometriosis. via openalex
Placebo-controlled comparison of hormonal and biochemical effects of danazol and high-dose medroxyprogesterone acetate via openalex
The aetiology and pathogenesis of endometriosis via openalex
Tissue and endocrine responses to gestrinone and danazol in the treatment of endometriosis via openalex
Treatment of endometriosis with gestrinone (R-2323), a synthetic antiestrogen, antiprogesterone via openalex
Vocal effects of danazol therapy via openalex
W6715458637 via openalex
W6845012053 via openalex
doi:10.1016/s0892-1997(88)80028-6 via openalex
doi:10.1016/s0015-0282(16)48729-7 via openalex
doi:10.1136/bmj.287.6397.946 via openalex
doi:10.1016/s0015-0282(16)60722-7 via openalex
doi:10.1016/s0015-0282(16)60666-0 via openalex
doi:10.1001/jama.1979.03290450079038 via openalex
doi:10.1111/j.1479-828x.1990.tb03232.x via openalex
doi:10.1016/s0015-0282(16)55205-4 via openalex
doi:10.1016/s0015-0282(16)48431-1 via openalex
doi:10.5694/j.1326-5377.1972.tb88172.x via openalex
doi:10.1016/s0015-0282(16)59765-9 via openalex
doi:10.5694/j.1326-5377.1993.tb121886.x via openalex
doi:10.1016/s0892-1997(05)80130-4 via openalex
doi:10.1016/0196-0709(90)90079-b via openalex
doi:10.3109/13682829109011991 via openalex
W1573917939 via openalex
doi:10.1097/00006254-197103000-00016 via openalex
doi:10.1016/s0015-0282(16)46151-0 via openalex
W2403905984 via openalex
doi:10.1044/jshr.3103.338 via openalex
W6600720097 via openalex
W6605565427 via openalex
W6634104453 via openalex
W6634341700 via openalex

Source provenance

europepmc: last seen: 2026-07-27T06:15:28.040536+00:00
openalex: last seen: 2026-05-11T06:24:00.257642+00:00
pubmed: last seen: 2026-05-13T22:10:35.327253+00:00

License: CC0 · commercial use OK

[1] A comparative study of danazol, a regimen of decreasing doses of danazol, and norethindrone in the treatment of objectively proven unexplained menorrhagia via openalex

[2] A Comparative Treatment Trial of Endometriosis Using the Gonadotrophin‐releasing Hormone Agonist, Nafarelin, and the Synthetic Steroid, Danazol via openalex

[3] Action of danazol on plasma lipids and lipoprotein metabolism. via openalex

[4] A randomized double-blind prospective trial of two doses of gestrinone in the treatment of endometriosis via openalex

[5] Effect Of Danazol On Vocal Pitch - A Case-study via openalex

[6] Endometriosis—Associated Infertility via openalex

[7] ETIOLOGY, PREVENTION, AND INHIBITION OF ENDOMETRIOSIS via openalex

[8] Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis. via openalex

[9] Goserelin (Zoladex) and the skeleton via openalex

[10] Goserelin (Zoladex ) depot in the treatment of endometriosis via openalex

[11] Hormonal therapies for endometriosis: implications for bone metabolism. via openalex

[12] Incidence of endometriosis in diagnostic laparoscopy. via openalex

[13] LAPAROSCOPIC DIAGNOSIS AND PSEUDOMENOPAUSE TREATMENT OF ENDOMETRIOSIS WITH DANAZOL via openalex

[14] Laparoscopy in the diagnosis and management of endometriosis. via openalex

[15] Placebo-controlled comparison of hormonal and biochemical effects of danazol and high-dose medroxyprogesterone acetate via openalex

[16] The aetiology and pathogenesis of endometriosis via openalex

[17] Tissue and endocrine responses to gestrinone and danazol in the treatment of endometriosis via openalex

[18] Treatment of endometriosis with gestrinone (R-2323), a synthetic antiestrogen, antiprogesterone via openalex

[19] Vocal effects of danazol therapy via openalex

[20] W6715458637 via openalex

[21] W6845012053 via openalex

[22] doi:10.1016/s0892-1997(88)80028-6 via openalex

[23] doi:10.1016/s0015-0282(16)48729-7 via openalex

[24] doi:10.1136/bmj.287.6397.946 via openalex

[25] doi:10.1016/s0015-0282(16)60722-7 via openalex

[26] doi:10.1016/s0015-0282(16)60666-0 via openalex

[27] doi:10.1001/jama.1979.03290450079038 via openalex

[28] doi:10.1111/j.1479-828x.1990.tb03232.x via openalex

[29] doi:10.1016/s0015-0282(16)55205-4 via openalex

[30] doi:10.1016/s0015-0282(16)48431-1 via openalex

[31] doi:10.5694/j.1326-5377.1972.tb88172.x via openalex

[32] doi:10.1016/s0015-0282(16)59765-9 via openalex

[33] doi:10.5694/j.1326-5377.1993.tb121886.x via openalex

[34] doi:10.1016/s0892-1997(05)80130-4 via openalex

[35] doi:10.1016/0196-0709(90)90079-b via openalex

[36] doi:10.3109/13682829109011991 via openalex

[37] W1573917939 via openalex

[38] doi:10.1097/00006254-197103000-00016 via openalex

[39] doi:10.1016/s0015-0282(16)46151-0 via openalex

[40] W2403905984 via openalex

[41] doi:10.1044/jshr.3103.338 via openalex

[42] W6600720097 via openalex

[43] W6605565427 via openalex

[44] W6634104453 via openalex

[45] W6634341700 via openalex